Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Preview:

DESCRIPTION

Efficacy and Safety of the Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) in 411 Patients With Melanoma. Presented By Antoni Ribas at 2014 ASCO Annual Meeting. Disclosures. Presented By Antoni Ribas at 2014 ASCO Annual Meeting. - PowerPoint PPT Presentation

Citation preview

Efficacy and Safety of the Anti-PD-1 <br />Monoclonal Antibody Pembrolizumab (MK-3475) in 411 Patients With Melanoma

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Disclosures

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Pembrolizumab and Available Clinical Data: KEYNOTE-001 (NCT01295827)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

411 Patients in Melanoma Expansion Cohorts: KEYNOTE-001

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

KEYNOTE-001 Eligibility Criteria

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

KEYNOTE-001 Eligibility Criteria

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Baseline Characteristics (1)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Baseline Characteristics (2)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Summary of Exposurea and <br />Treatment-Related AEs by Prior IPI

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Treatment-Related AEs With Incidence >5%

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Immune-Mediated AEs

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Maximum Percent Change from Baseline in Tumor Sizea (Central Review, RECIST v1.1)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Maximum Percent Change from Baseline in Tumor Sizea (Central Review, irRC)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Confirmed ORR in Subgroups (Central Review, RECIST v1.1)

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Antitumor Activity by Prior Ipilimumab and Pembrolizumab Dose/Schedule

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Slide 16

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Kaplan-Meier Estimate of PFS per RECIST 1.1, Independent Central Review

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Kaplan-Meier Estimate of Overall Survival

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Summary

Presented By Antoni Ribas at 2014 ASCO Annual Meeting

Acknowledgments

Presented By Antoni Ribas at 2014 ASCO Annual Meeting